Clinical Trial Update: Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic Phase [Phase 4]

View source ↗

Summary

A Phase 4 study evaluates tolerability, feasibility, and effectiveness of nifurtimox-eflornithine combination therapy (NECT) for late-stage Human African trypan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Eflornithine (eflornithine)
• Nifurtimox (Nifurtimox)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Human African Trypanosomiasis | Phase 4 | Status: COMPLETED